Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan versus propranolol versus placebo for portal hypertension
ChiCTR-TRC-09000426Phase 4Completed
- Sponsor
- PLA General Hospital Fifth Medical Center
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of losartan and propranolol in Portal Hypertension (PH) (3 arms), sponsored by PLA General Hospital Fifth Medical Center. Primary endpoint: Hepatic and splenic arterial resistance and pulsatility indices and portal hypertension index. Started Jun 2009; status: completed.
02
Drugs
losartanpropranolol
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on ChiCTR-TRC-09000426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000426.